181 related articles for article (PubMed ID: 35962814)
1. History of keratinocyte carcinoma and survival after a second primary malignancy: the Moffitt Cancer Center patient experience.
Amorrortu RP; Zhao Y; Stewart S; Ghia KM; Williams VL; Sondak VK; Tsai KY; Pinilla J; Chavez J; Rollison DE
J Cancer Res Clin Oncol; 2023 Jul; 149(7):3607-3621. PubMed ID: 35962814
[TBL] [Abstract][Full Text] [Related]
2. Melanoma and CLL co-occurrence and survival: role of KC history.
Zhao Y; Amorrortu RP; Stewart SC; Ghia KM; Williams VL; Sondak VK; Tsai KY; Pinilla-Ibarz J; Chavez JC; Rollison DE
BMC Cancer; 2023 Nov; 23(1):1084. PubMed ID: 37946198
[TBL] [Abstract][Full Text] [Related]
3. Risk of melanoma following keratinocyte malignancies.
Robinson SN; Zens MS; Rees JR; Barton DT; Karagas MR
Int J Cancer; 2020 Oct; 147(8):2116-2120. PubMed ID: 32285932
[TBL] [Abstract][Full Text] [Related]
4. Personal history of keratinocyte carcinoma is associated with reduced risk of death from invasive melanoma in men.
Song F; Chen ST; Li X; Han J
J Am Acad Dermatol; 2018 May; 78(5):957-963. PubMed ID: 29317282
[TBL] [Abstract][Full Text] [Related]
5. Risk of Venous Thromboembolism in Patients With Keratinocyte Carcinoma.
Rudy SF; Li K; Moubayed SP; Most SP
JAMA Facial Plast Surg; 2018 Dec; 20(6):453-459. PubMed ID: 29800029
[TBL] [Abstract][Full Text] [Related]
6. A collision of diseases: chronic lymphocytic leukemia discovered during lymph node biopsy for melanoma.
Farma JM; Zager JS; Barnica-Elvir V; Puleo CA; Marzban SS; Rollison DE; Messina JL; Sondak VK
Ann Surg Oncol; 2013 Apr; 20(4):1360-4. PubMed ID: 23179994
[TBL] [Abstract][Full Text] [Related]
7. Association of advanced leukemic stage and skin cancer tumor stage with poor skin cancer outcomes in patients with chronic lymphocytic leukemia.
Velez NF; Karia PS; Vartanov AR; Davids MS; Brown JR; Schmults CD
JAMA Dermatol; 2014 Mar; 150(3):280-7. PubMed ID: 24429548
[TBL] [Abstract][Full Text] [Related]
8. History of Keratinocyte Carcinoma and Risk of Melanoma: A Prospective Cohort Study.
Wu S; Cho E; Li WQ; Qureshi AA
J Natl Cancer Inst; 2017 Apr; 109(4):. PubMed ID: 28376160
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for keratinocyte skin cancer in patients diagnosed with melanoma, a large retrospective study.
Espinosa P; Pfeiffer RM; García-Casado Z; Requena C; Landi MT; Kumar R; Nagore E
Eur J Cancer; 2016 Jan; 53():115-24. PubMed ID: 26702765
[TBL] [Abstract][Full Text] [Related]
10. Risk Factors for Melanoma Among Survivors of Non-Hodgkin Lymphoma.
Lam CJ; Curtis RE; Dores GM; Engels EA; Caporaso NE; Polliack A; Warren JL; Young HA; Levine PH; Elmi AF; Fraumeni JF; Tucker MA; Morton LM
J Clin Oncol; 2015 Oct; 33(28):3096-104. PubMed ID: 26240221
[TBL] [Abstract][Full Text] [Related]
11. Melanoma in patients with chronic lymphocytic leukemia and non-Hodgkin lymphoma.
Famenini S; Martires KJ; Zhou H; Xavier MF; Wu JJ
J Am Acad Dermatol; 2015 Jan; 72(1):78-84. PubMed ID: 25440434
[TBL] [Abstract][Full Text] [Related]
12. The clinical course of lung carcinoma in patients with chronic lymphocytic leukemia.
Parekh K; Rusch V; Kris M
Cancer; 1999 Nov; 86(9):1720-3. PubMed ID: 10547544
[TBL] [Abstract][Full Text] [Related]
13. Risk of second primary cancer associated with pre-diagnostic smoking, alcohol, and obesity in women with keratinocyte carcinoma.
Park SM; Li T; Wu S; Li WQ; Qureshi AA; Stampfer M; Cho E
Cancer Epidemiol; 2017 Apr; 47():106-113. PubMed ID: 28242577
[TBL] [Abstract][Full Text] [Related]
14. Chronic lymphocytic leukemia is associated with decreased survival of patients with malignant melanoma and Merkel cell carcinoma in a SEER population-based study.
Brewer JD; Shanafelt TD; Otley CC; Roenigk RK; Cerhan JR; Kay NE; Weaver AL; Call TG
J Clin Oncol; 2012 Mar; 30(8):843-9. PubMed ID: 22331952
[TBL] [Abstract][Full Text] [Related]
15. Melanoma survivors are at increased risk for second primary keratinocyte carcinoma.
Sun H; Li Y; Zeng F; Meng Y; Du S; Deng G
Int J Dermatol; 2022 Nov; 61(11):1397-1404. PubMed ID: 35726477
[TBL] [Abstract][Full Text] [Related]
16. Incidence and prognostic impact of other cancers in a population of long-term survivors of chronic lymphocytic leukemia.
Falchi L; Vitale C; Keating MJ; Lerner S; Wang X; Elhor Gbito KY; Strom S; Wierda WG; Ferrajoli A
Ann Oncol; 2016 Jun; 27(6):1100-1106. PubMed ID: 26912560
[TBL] [Abstract][Full Text] [Related]
17. Increased incidence and recurrence rates of nonmelanoma skin cancer in patients with non-Hodgkin lymphoma: a Rochester Epidemiology Project population-based study in Minnesota.
Brewer JD; Shanafelt TD; Khezri F; Sosa Seda IM; Zubair AS; Baum CL; Arpey CJ; Cerhan JR; Call TG; Roenigk RK; Smith CY; Weaver AL; Otley CC
J Am Acad Dermatol; 2015 Feb; 72(2):302-9. PubMed ID: 25479909
[TBL] [Abstract][Full Text] [Related]
18. Management of melanoma in patients with chronic lymphocytic leukemia.
Archibald WJ; Meacham PJ; Williams AM; Baran AM; Victor AI; Barr PM; Sahasrahbudhe DM; Zent CS
Leuk Res; 2018 Aug; 71():43-46. PubMed ID: 30005183
[TBL] [Abstract][Full Text] [Related]
19. Second cancers in patients with chronic lymphocytic leukemia.
Travis LB; Curtis RE; Hankey BF; Fraumeni JF
J Natl Cancer Inst; 1992 Sep; 84(18):1422-7. PubMed ID: 1512794
[TBL] [Abstract][Full Text] [Related]
20. The effect of menopausal hormone therapy on the risk of melanoma and keratinocyte skin cancer: A systematic review and meta-analysis of observational studies.
Lallas K; Anagnostis P; Theocharis P; Boureka E; Kyrgidis A; Klonos E; Papazisis G; Apalla Z; Lallas A; Vakirlis E
Maturitas; 2023 Feb; 168():20-28. PubMed ID: 36372010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
